Advanced glycation end products (AGEs) Persistent hyperglycemic state in DM could result in non-enzymatic glycation reaction of proteins and lipids and nucleic acid leading to the generation of advanced glycated end products (AGEs), which induce insulin resistance (Ottum and Mistry 2015) and have a vital role in the pathophysiology of diabetic complications (Khalid et al
While Ipamorelin alone has modest fat loss effects, when combined with CJC-1295 (a GHRH analog), it creates a synergistic GH elevation that enhances body recomposition
(The Efficacy Picture) Weight loss TRIUMPH-1 (n = 2,339, 80 weeks) The largest obesity drug trial ever conducted
Improving insulin sensitivity through GIP receptor activation while simultaneously reducing caloric intake via delayed gastric emptying and prolonged satiety
Unlike fad diets that fight your biology, GLP-1 therapy works with your hormonal pathways, producing sustained, medically significant weight loss without constant restriction